United States - English - NLM (National Library of Medicine)

aspen global inc. - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 2 mg - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - chlorambucil - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chlorambucil - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chlorambucil - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - chlorambucil - oral tablet - 2mg

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - chlorambucil - film-coated tablet - chlorambucil 2 mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 9.9 g in 10 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 99 g in 100 g

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - chlorambucil, quantity: 2 mg - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of hodgkin's disease, certain forms of non-hodgkin's lymphoma, chronic lymphocytic leukaemia, waldenstrom's macroglobulinaemia, advanced ovarian adenocarcinoma. leukeran has a significant effect in a proportion of patients with breast cancer

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) -